Ten recommendations for sarcoma surgery: consensus of the surgical societies based on the German S3 guideline "Adult Soft Tissue Sarcomas".
Delphi process
Evidence
Sarcoma guideline
Surgical recommendation
Journal
Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285
Informations de publication
Date de publication:
11 Jul 2023
11 Jul 2023
Historique:
received:
07
05
2023
accepted:
25
06
2023
medline:
12
7
2023
pubmed:
11
7
2023
entrez:
10
7
2023
Statut:
epublish
Résumé
The evidence-based (S3) guideline "Adult Soft Tissue Sarcomas" (AWMF Registry No. 032/044OL) published by the German Guideline Program in Oncology (GGPO) covers all aspects of sarcoma treatment with 229 recommendations. Representatives of all medical specialties involved in sarcoma treatment contributed to the guideline. This paper compiles the most important recommendations for surgeons selected by delegates from the surgical societies. A Delphi process was used. Delegates from the surgical societies involved in guideline process selected the 15 recommendations that were most important to them. Votes for similar recommendations were tallied. From the resulting ranked list, the 10 most frequently voted recommendations were selected and confirmed by consensus in the next step. The statement "Resection of primary soft tissue sarcomas of the extremities should be performed as a wide resection. The goal is an R0 resection" was selected as the most important term. The next highest ranked recommendations were the need for a preoperative biopsy, performing preoperative MRI imaging with contrast, and discussing all cases before surgery in a multidisciplinary sarcoma committee. The evidence-based guideline "Adult Soft Tissue Sarcomas" is a milestone to improve the care of sarcoma patients in Germany. The selection of the top ten recommendations by surgeons for surgeons has the potential to improve the dissemination and acceptance of the guideline and thus improve the overall outcome of sarcoma patients.
Identifiants
pubmed: 37430129
doi: 10.1007/s00423-023-03002-3
pii: 10.1007/s00423-023-03002-3
pmc: PMC10333354
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
272Informations de copyright
© 2023. The Author(s).
Références
Eur J Surg Oncol. 2018 Sep;44(9):1324-1330
pubmed: 29885983
Ann Surg Oncol. 2012 Sep;19(9):2981-91
pubmed: 22476756
Ann Surg Oncol. 2019 Jul;26(7):2286-2293
pubmed: 31065964
Eur J Surg Oncol. 2022 May;48(5):994-1000
pubmed: 34848102
BMC Health Serv Res. 2012 Mar 28;12:82
pubmed: 22455759
Sarcoma. 2004;8(1):1-6
pubmed: 18521386
Sarcoma. 2010;2010:506182
pubmed: 20634933
Eur J Surg Oncol. 2008 Jun;34(6):680-6
pubmed: 17716851
Eur J Cancer. 2023 Feb;180:158-179
pubmed: 36599184
Cancer. 2017 Feb 15;123(4):560-567
pubmed: 27859013
Cancer. 2018 Mar 15;124(6):1179-1187
pubmed: 29211310
J Natl Compr Canc Netw. 2007 Jul;5 Suppl 2:S1-29; quiz S30
pubmed: 17624289
Cancers (Basel). 2021 Apr 02;13(7):
pubmed: 33918457
Cancer. 2020 Jan 1;126(9):1917-1928
pubmed: 32022262
BMC Cancer. 2022 Jun 7;22(1):621
pubmed: 35672675
Ann Oncol. 2019 Jul 1;30(7):1143-1153
pubmed: 31081028
BMC Public Health. 2018 Feb 12;18(1):235
pubmed: 29433465
Ann Oncol. 2017 Nov 01;28(11):2852-2859
pubmed: 29117335
J Clin Oncol. 2018 Mar 1;36(7):704-709
pubmed: 29346043
Clin Sarcoma Res. 2016 Nov 15;6:20
pubmed: 27891213
Eur J Surg Oncol. 2012 Apr;38(4):346-51
pubmed: 22264775
Ann Oncol. 2008 May;19 Suppl 2:ii89-93
pubmed: 18456783
PLoS One. 2021 Jun 4;16(6):e0252381
pubmed: 34086725
Pathologica. 2021 Apr;113(2):70-84
pubmed: 33179614
Lancet Oncol. 2017 Aug;18(8):1022-1039
pubmed: 28687376
Ann Oncol. 2021 Nov;32(11):1348-1365
pubmed: 34303806
Clin Orthop Relat Res. 2017 Feb;475(2):511-518
pubmed: 27655183
BMC Cancer. 2021 May 29;21(1):631
pubmed: 34049529
Eur J Surg Oncol. 2019 Feb;45(2):249-253
pubmed: 30082178
J Bone Joint Surg Br. 2008 Feb;90(2):203-8
pubmed: 18256089